Schrijvers A - Search Results

1

Monoclonal antibodies for diagnosis and therapy of squamous cell carcinoma of the head and neck.

Gripp FM, Quak J, Leverstein H, Schrijvers A, Gerretsen M, Brakenhoff R, Van Dongen G, Snow GB, Rapoport A. Gripp FM, et al. Among authors: schrijvers a. Sao Paulo Med J. 1994 Jul-Sep;112(3):612-21. doi: 10.1590/s1516-31801994000300008. Sao Paulo Med J. 1994. PMID: 7638523 Review. No abstract available.

2

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.

Gerretsen M, Schrijvers AH, van Walsum M, Braakhuis BJ, Quak JJ, Meijer CJ, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: schrijvers ah. Br J Cancer. 1992 Sep;66(3):496-502. doi: 10.1038/bjc.1992.302. Br J Cancer. 1992. PMID: 1520586 Free PMC article.

3

Detection of squamous cell carcinoma xenografts in nude mice by radiolabeled monoclonal antibody E48.

Quak JJ, Gerretsen M, Schrijvers AH, Meijer CJ, van Dongen GA, Snow GB. Quak JJ, et al. Among authors: schrijvers ah. Arch Otolaryngol Head Neck Surg. 1991 Nov;117(11):1287-91. doi: 10.1001/archotol.1991.01870230103017. Arch Otolaryngol Head Neck Surg. 1991. PMID: 1747235

4

Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma.

Schrijvers AH, Gerretsen M, Fritz JM, van Walsum M, Quak JJ, Snow GB, van Dongen GA. Schrijvers AH, et al. Exp Cell Res. 1991 Oct;196(2):264-9. doi: 10.1016/0014-4827(91)90260-2. Exp Cell Res. 1991. PMID: 1893937

5

MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.

Schrijvers AH, Quak JJ, Uyterlinde AM, van Walsum M, Meijer CJ, Snow GB, van Dongen GA. Schrijvers AH, et al. Cancer Res. 1993 Sep 15;53(18):4383-90. Cancer Res. 1993. PMID: 8364934

6

Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984.

Schrijvers AH, Gerretsen M, van Walsum M, Braakhuis BJ, Quak JJ, Snow GB, van Dongen GA. Schrijvers AH, et al. Cancer Immunol Immunother. 1992;34(4):252-8. doi: 10.1007/BF01741793. Cancer Immunol Immunother. 1992. PMID: 1371426 Free PMC article.

7

Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.

Schöffski P, Catimel G, Planting AS, Droz JP, Verweij J, Schrijvers D, Gras L, Schrijvers A, Wanders J, Hanauske AR. Schöffski P, et al. Among authors: schrijvers d, schrijvers a. Ann Oncol. 1999 Jan;10(1):119-22. doi: 10.1023/a:1008360323986. Ann Oncol. 1999. PMID: 10076732 Free article. Clinical Trial.

8

Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group.

Joerger M, Huitema AD, Richel DJ, Dittrich C, Pavlidis N, Briasoulis E, Vermorken JB, Strocchi E, Martoni A, Sorio R, Sleeboom HP, Izquierdo MA, Jodrell DI, Calvert H, Boddy AV, Hollema H, Féty R, Van der Vijgh WJ, Hempel G, Chatelut E, Karlsson M, Wilkins J, Tranchand B, Schrijvers AH, Twelves C, Beijnen JH, Schellens JH. Joerger M, et al. Among authors: schrijvers ah. Clin Cancer Res. 2007 Nov 1;13(21):6410-8. doi: 10.1158/1078-0432.CCR-07-0064. Clin Cancer Res. 2007. PMID: 17975154

9

The effect of food on the pharmacokinetics of S-1 after single oral administration to patients with solid tumors.

Peters GJ, Noordhuis P, Van Groeningen CJ, Giaccone G, Holwerda U, Voorn D, Schrijvers A, Schornagel JH, Beijnen JH, Fumoleau P, Schellens JH. Peters GJ, et al. Among authors: schrijvers a. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4072-6. doi: 10.1158/1078-0432.CCR-1076-03. Clin Cancer Res. 2004. PMID: 15217941 Clinical Trial.

10

An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours.

Awada A, Thödtmann R, Piccart MJ, Wanders J, Schrijvers AH, Von Broen IM, Hanauske AR; EORTC-ECSG phase I study. Awada A, et al. Among authors: schrijvers ah. Eur J Cancer. 2003 Apr;39(6):742-7. doi: 10.1016/s0959-8049(02)00776-1. Eur J Cancer. 2003. PMID: 12651198 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters